contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


nordhealth-oy-nordhealth-as-granting-of-performance-based-options-to-executive-management-and-key-employees

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

NordHealth operates in the technology industry. The company specializes in developing software for digital health. The software is developed in-house and is mainly used in the healthcare sector. Customers consist of corporate customers operating in various sectors such as hospitals, clinics, veterinarians. In addition to the main business, various value-added services are also offered. The largest operations are found in the Nordic region.

NordHealth

Helsinki, Finland, 30 September 2025: The board of Nordhealth AS (the "Company") has today approved the allocation of a maximum of 7,217,260 options linked to the Company's shares under an incentive...

Helsinki, Finland, 30 September 2025: The board of Nordhealth AS (the "Company") has today approved the allocation of a maximum of 7,217,260 options linked to the Company's shares under an incentive scheme (the "Options") to members of the Company's executive management and key employees. The Options vest based on a combination of time-based and share price-based performance. The time-based vesting is quarterly, over 4 years (1-year cliff). The performance-based vesting requires a minimum of 11% annual compounding growth in the share price from the start date (i.e. 10% or less annual growth means no options vest). The maximum Options vest if 25% or higher compounding share price growth has been achieved. There is a linear increase in vesting between 10% and 25%.The vested Options may be exercised in designated exercise windows during a five year period subject to a possible extension of three additional years. The settlement of the Options may consist of shares on a one-for-one basis and/or cash at the discretion of the Company. The following primary insiders and a close associate have been granted Options: <ul>	<li>Charles MacBain, CEO of the Company, was granted a maximum of 2,405,753 Options. </li>	<li>Alexander Cram, CFO of the Company, was granted a maximum of 1,202,877 Options. </li>	<li>A1KW B.V., a close associate of Karan Wallia, Therapy BU CEO, was granted a maximum of 2,405,753 Options. </li></ul>Please refer to the attached notifications of trading for further details.For further information, please contact:Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12.<div></div>

Nordhealth Oy: Nordhealth AS: Granting of performance-based options to executive management and key employees